Stay updated on Insulin Degludec vs Glargine U100 in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Degludec vs Glargine U100 in Type 2 Diabetes Clinical Trial page.

Latest updates to the Insulin Degludec vs Glargine U100 in Type 2 Diabetes Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s footer indicates the ClinicalTrials.gov interface was revised from v3.5.2 to v3.5.3. This reflects a site/version update rather than a change to the study record itself.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No user-facing content changes are indicated.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision history updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.0%

- Check81 days agoChange DetectedAn administrative site update adds Revision: v3.4.2, and a government funding status notice was removed (Revision: v3.4.1). These changes do not affect study details, eligibility criteria, or results on the page.SummaryDifference0.4%

- Check89 days agoChange DetectedThe page now includes a site-wide notice about government funding and a version update from 3.4.0 to 3.4.1; there are no changes to study data, eligibility criteria, or results content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Insulin Degludec vs Glargine U100 in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Degludec vs Glargine U100 in Type 2 Diabetes Clinical Trial page.